Thickness of superficial basal cell carcinoma (sBCC) predicts imiquimod efficacy: a proposal for a thickness-based definition of sBCC.

@article{McKay2013ThicknessOS,
  title={Thickness of superficial basal cell carcinoma (sBCC) predicts imiquimod efficacy: a proposal for a thickness-based definition of sBCC.},
  author={Kristopher Michael McKay and Brittany L Sambrano and Patricia S. Fox and Roland L. Bassett and S Chon and Victor G Prieto},
  journal={The British journal of dermatology},
  year={2013},
  volume={169 3},
  pages={549-54}
}
BACKGROUND Basal cell carcinoma (BCC) is the most common malignancy in the white population. It is an important driver of healthcare costs and causes significant morbidity. Topical imiquimod is a good noninvasive treatment alternative for surgical excision in superficial BCC (sBCC). However, there are currently no uniform histological definitions of sBCC. A definition based on tumour thickness might be a good alternative. OBJECTIVES To determine whether tumour thickness in sBCC is a predictor… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

Aktuelle Diagnostik und Behandlung des Basalzellkarzinoms.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG • 2015

Similar Papers

Loading similar papers…